ロード中...
Sulfasalazine-Induced Interstitial Fibrosis
Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years. Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare. Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalaz...
保存先:
| 出版年: | Eurasian J Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Eurasian Journal of Medicine
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6263240/ https://ncbi.nlm.nih.gov/pubmed/30515045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurasianjmed.2018.17302 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|